Lloyd Klickstein

CIK: 0001776004

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ACET

Adicet Bio, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

ACET
Adicet Bio, Inc.
Aug 5, 2026
Award(A)
Stock Option (Right to Buy)
Direct
18.3K shares-
ACET
Adicet Bio, Inc.
Jun 21, 2026
Award(A)
Stock Option (Right to Buy)
Direct
4.2K shares-
ACET
Adicet Bio, Inc.
Jun 11, 2025
Award(A)
Direct
5.9K shares-

		Type	Shares	Price		Ownership
Aug 5, 2026	ACET Adicet Bio, Inc.	Award(A) Stock Option (Right to Buy)	18,300	-	-	Direct
Jun 21, 2026	ACET Adicet Bio, Inc.	Award(A) Stock Option (Right to Buy)	4,200	-	-	Direct
Jun 11, 2025	ACET Adicet Bio, Inc.	Award(A)	5,900	-	-	Direct

1-3 of 3 transactions

About Klickstein Lloyd

Klickstein Lloyd (SEC CIK 0001776004) files insider reports with the SEC as Chief Medical Officer of Adicet Bio, Inc. (ACET).

Signal8 holds 3 ownership filings by Klickstein Lloyd, all Form 4s, filed between Jun 13, 2025 and Aug 7, 2026. Those filings report 3 transactions, from Jun 11, 2025 to Aug 5, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Klickstein Lloyd's filings is in BOSTON, MA.

Recent filings by Klickstein Lloyd

Aug 5, 2026: Grant or award of ACET derivative securities (Form 4, code A).
Jun 21, 2026: Grant or award of ACET derivative securities (Form 4, code A).
Jun 11, 2025: Grant or award of ACET shares (Form 4, code A).

Other insiders filing for Adicet Bio, Inc. (ACET)

Schor Chen, President & CEO
Aftab Blake, Chief Scientific Officer
DUBIN STEVE, Director
Chodakewitz Jeffrey, Director
Grissinger Michael, Director
Sinclair Andrew, Director

How to read Form 4 transaction codes